Immunomodulatory Agent CC-11006

**Semantic type:** Pharmacologic Substance

**Definition:** A proprietary, orally available, small molecule and thalidomide analog, with potential immunomodulating and antineoplastic activity. CC-11006 appears to have a similar mechanism to thalidomide and may modulate the expression of proinflammatory and regulatory cytokines.

**Synonyms:** - CC-11006 - CC-11006 - CC-11006-MDS-001